UBS Group has lowered the Target Price for Moderna to 96 dollars.

Gelonghui, January 9｜UBS Group: Downgraded Moderna's Target Price from $108 to $96, maintaining a "Buy" rating. (Gelonghui)

Gelonghui Finance17:40 · Ratings

Fed Meeting Minutes Leave Equities Mixed

MT Newswires05:57

Moderna Options Spot-On: On January 8th, 167.25K Contracts Were Traded, With 712.63K Open Interest

On January 8th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 167.25K options for the day, of which put options accounted for 66.44% of the total transactions, and

Futu News05:30

Equities Largely Unchanged After Labor Market Data, Fed Governor Remarks

MT Newswires03:09

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

Benzinga01:54

Moderna Analyst Ratings

BenzingaJan 8 23:03 · Ratings